Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study.
Feng YeYanzhao ZhouXinyuan ZhangYujing XinYi ChenQingsheng FanXiao LiXi WeiQiang LiXiang ZhouJinxue ZhouPublished in: Journal of hepatocellular carcinoma (2021)
The aMAP score provided a well-discriminated risk stratification and is an independent prognostic factor for the late recurrence of HCC following RFA. The aMAP score-based nomogram could help to strengthen prognosis-based decision making and formulate adjuvant therapeutic and preventive strategies.